153 related articles for article (PubMed ID: 7504120)
21. Expression of insulin-like growth factor binding protein 2 (IGFBP-2) in Wilms' tumors.
Vincent TS; Garvin AJ; Gramling TS; Hazen-Martin DJ; Re GG; Sens DA
Pediatr Pathol; 1994; 14(4):723-30. PubMed ID: 7526357
[TBL] [Abstract][Full Text] [Related]
22. Enhanced expression of insulin-like growth factor II is not a necessary event in Wilms' tumour progression.
Little MH; Ablett G; Smith PJ
Carcinogenesis; 1987 Jun; 8(6):865-8. PubMed ID: 3038359
[TBL] [Abstract][Full Text] [Related]
23. Expression and CpG methylation of the insulin-like growth factor II gene in human smooth muscle tumors.
Gloudemans T; Pospiech I; Van Der Ven LT; Lips CJ; Schneid H; Den Otter W; Sussenbach JS
Cancer Res; 1992 Dec; 52(23):6516-21. PubMed ID: 1358435
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor-II (IGF-II) messenger ribonucleic acid is expressed in steroidogenic cells of the developing ovine adrenal gland: evidence of an autocrine/paracrine role for IGF-II.
Han VK; Lu F; Bassett N; Yang KP; Delhanty PJ; Challis JR
Endocrinology; 1992 Dec; 131(6):3100-9. PubMed ID: 1446644
[TBL] [Abstract][Full Text] [Related]
25. The candidate Wilms' tumour gene is involved in genitourinary development.
Pritchard-Jones K; Fleming S; Davidson D; Bickmore W; Porteous D; Gosden C; Bard J; Buckler A; Pelletier J; Housman D
Nature; 1990 Jul; 346(6280):194-7. PubMed ID: 2164159
[TBL] [Abstract][Full Text] [Related]
26. [Nicotinic acetylcholine receptors in tumors with rhabdomyomatous differentiation. Immunohistochemical amd molecular genetic demonstration].
Kirchner T; Geuder KI; Marx A; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1990; 74():409-14. PubMed ID: 1708627
[TBL] [Abstract][Full Text] [Related]
27. Blastemal cells of nephroblastomatosis complex share an onco-developmental antigen with embryonic kidney and Wilms' tumor. An immunohistochemical study on polysialic acid distribution.
Roth J; Blaha I; Bitter-Suermann D; Heitz PU
Am J Pathol; 1988 Dec; 133(3):596-608. PubMed ID: 2849302
[TBL] [Abstract][Full Text] [Related]
28. Insulin-like growth factor-II in nonislet cell tumors associated with hypoglycemia: increased levels of messenger ribonucleic acid.
Lowe WL; Roberts CT; LeRoith D; Rojeski MT; Merimee TJ; Fui ST; Keen H; Arnold D; Mersey J; Gluzman S
J Clin Endocrinol Metab; 1989 Dec; 69(6):1153-9. PubMed ID: 2584352
[TBL] [Abstract][Full Text] [Related]
29. Expression of insulin-like growth factor II, alpha-fetoprotein and hepatitis B virus transcripts in human primary liver cancer.
Cariani E; Lasserre C; Kemeny F; Franco D; Brechot C
Hepatology; 1991 Apr; 13(4):644-9. PubMed ID: 1707028
[TBL] [Abstract][Full Text] [Related]
30. Enhanced expression of the N-myc gene in Wilms' tumors.
Nisen PD; Zimmerman KA; Cotter SV; Gilbert F; Alt FW
Cancer Res; 1986 Dec; 46(12 Pt 1):6217-22. PubMed ID: 2430692
[TBL] [Abstract][Full Text] [Related]
31. Molecular cloning of rat Wilms' tumor complementary DNA and a study of messenger RNA expression in the urogenital system and the brain.
Sharma PM; Yang X; Bowman M; Roberts V; Sukumar S
Cancer Res; 1992 Nov; 52(22):6407-12. PubMed ID: 1330293
[TBL] [Abstract][Full Text] [Related]
32. Localization of insulin-like growth factor-II and hepatitis B virus mRNAs and proteins in human hepatocellular carcinomas.
Lamas E; Le Bail B; Housset C; Boucher O; Bréchot C
Lab Invest; 1991 Jan; 64(1):98-104. PubMed ID: 1846656
[TBL] [Abstract][Full Text] [Related]
33. Expression of insulin-like growth factor in adult and embryonic kidney.
Hammerman MR; Ryan G; Miller SB
Miner Electrolyte Metab; 1992; 18(2-5):253-5. PubMed ID: 1465070
[TBL] [Abstract][Full Text] [Related]
34. Expression of insulin-like growth factor-II transcripts in Wilms' tumour.
Reeve AE; Eccles MR; Wilkins RJ; Bell GI; Millow LJ
Nature; 1985 Sep 19-25; 317(6034):258-60. PubMed ID: 2995817
[TBL] [Abstract][Full Text] [Related]
35. Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth.
Schirmacher P; Held WA; Yang D; Chisari FV; Rustum Y; Rogler CE
Cancer Res; 1992 May; 52(9):2549-56. PubMed ID: 1568224
[TBL] [Abstract][Full Text] [Related]
36. Loss of heterozygosity in non-tumoral tissue in two children with Beckwith-Wiedemann syndrome.
Schneid H; Vazquez MP; Seurin D; le Bouc Y
Growth Regul; 1991 Dec; 1(4):168-70. PubMed ID: 1688177
[TBL] [Abstract][Full Text] [Related]
37. Molecular advances in pediatric urology.
Pressler LB; Burbige KA; Connor JP
Urology; 1995 Dec; 46(6):888-98. PubMed ID: 7502439
[No Abstract] [Full Text] [Related]
38. Immunohistochemical localization of transport mediators in Wilms' tumor: comparison with fetal and mature human kidney.
Hennigar RA; Garvin AJ; Hazen-Martin DJ; Schulte BA
Lab Invest; 1989 Aug; 61(2):192-201. PubMed ID: 2474091
[TBL] [Abstract][Full Text] [Related]
39. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1.
Drummond IA; Madden SL; Rohwer-Nutter P; Bell GI; Sukhatme VP; Rauscher FJ
Science; 1992 Jul; 257(5070):674-8. PubMed ID: 1323141
[TBL] [Abstract][Full Text] [Related]
40. Structural alteration of the insulin-like growth factor II-gene in Wilms tumour.
Irminger JC; Schoenle EJ; Briner J; Humbel RE
Eur J Pediatr; 1989 Jun; 148(7):620-3. PubMed ID: 2545450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
